MedTrace Logo

Alcohol Brief Intervention Plus Personalized Mobile Chat-based Intervention for High-risk Drinking University Students

NCT03675373 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2019-09-25

No results posted yet for this study

Summary

The aims of this pilot study are:

1. To examine the factors associated with alcohol drinking and alcohol use disorder
2. To examine the effect of face-to-face alcohol brief intervention on drinking reduction
3. To examine the effect of a continuous interactive chat-based intervention via "WhatsApp" on drinking reduction
4. To explore the perception of face-to-face alcohol brief intervention
5. To explore the perception of continuous interactive chat-based intervention via instant messaging mobile application "WhatsApp"

Conditions

  • Alcohol Drinking in College

Interventions

BEHAVIORAL

Mobile chat-based instant messages

Subjects in the active arm study will receive continuous interactive chat-based intervention as an extension of alcohol brief intervention at baseline. The interactive mobile chat will be carried out on Friday night and Saturday before and during the period of "happy hour" and ask for drinking and giving personalized advises on drinking reduction using behavioral change techniques.

BEHAVIORAL

Alcohol brief intervention

Those in the control arm will be assigned to only receive the face-to-face ABI. The ABI consists of: (1) giving feedback and information about the screening result in phase I and hazard of drinking; (2) emphasizing the benefits of reduce drinking and informing about alcohol problems; (3) setting goal on reducing alcohol consumption; (4) reviewing advice and ;(5) giving encouragement.

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Man Ping Wang, PhD · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
26 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-08
Primary Completion
2018-11-04
Completion
2019-01-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03675373 on ClinicalTrials.gov